120 related articles for article (PubMed ID: 12088293)
1. Prostate biopsies in men with limited life expectancy.
Wasson JH; Bubolz TA; Yao GL; Barry MJ
Eff Clin Pract; 2002; 5(3):137-42. PubMed ID: 12088293
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy.
Hoffman KE; Nguyen PL; Ng AK; D'Amico AV
J Urol; 2010 May; 183(5):1798-802. PubMed ID: 20299039
[TBL] [Abstract][Full Text] [Related]
3. The evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis.
Mold JW; Holtgrave DR; Bisonni RS; Marley DS; Wright RA; Spann SJ
J Fam Pract; 1992 May; 34(5):561-8. PubMed ID: 1578205
[TBL] [Abstract][Full Text] [Related]
4. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
[TBL] [Abstract][Full Text] [Related]
5. PROs favor observation of some prostate patients.
Hosp Peer Rev; 1995 Jul; 20(7):105-7. PubMed ID: 10153205
[No Abstract] [Full Text] [Related]
6. Do older men benefit from curative therapy of localized prostate cancer?
Alibhai SM; Naglie G; Nam R; Trachtenberg J; Krahn MD
J Clin Oncol; 2003 Sep; 21(17):3318-27. PubMed ID: 12947068
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis of cancer of the prostate (I): Advancements in knowledge and practice since the consensus conference of 1989. The "Cancer of the Prostate" subcommittee of the Committee of Oncology of the French Association of Urology].
Villers A; Grosclaude P; Haillot O; Abbou CC; Richard F; Boccon-Gibod L
Prog Urol; 1997 Jun; 7(3):508-15. PubMed ID: 9273082
[TBL] [Abstract][Full Text] [Related]
8. Re: Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy. K. E. Hoffman, P. L. Nguyen, A. K. Ng and A. V. D'Amico. J Urol 2010; 183: 1798-1802.
Neulander EZ
J Urol; 2011 May; 185(5):1982; author reply 1983. PubMed ID: 21421243
[No Abstract] [Full Text] [Related]
9. Prostate cancer Tx. Therapeutic options based on tumor grade, life expectancy, and patient preferences.
Cohen SP; Jaskulsky SR
Geriatrics; 2001 Feb; 56(2):39, 42, 47-8 passim. PubMed ID: 11219024
[TBL] [Abstract][Full Text] [Related]
10. How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing.
Farrell MH; Murphy MA; Schneider CE
Eff Clin Pract; 2002; 5(3):120-9. PubMed ID: 12088291
[TBL] [Abstract][Full Text] [Related]
11. American Cancer Society guideline for the early detection of prostate cancer: update 2010.
Wolf AM; Wender RC; Etzioni RB; Thompson IM; D'Amico AV; Volk RJ; Brooks DD; Dash C; Guessous I; Andrews K; DeSantis C; Smith RA;
CA Cancer J Clin; 2010; 60(2):70-98. PubMed ID: 20200110
[TBL] [Abstract][Full Text] [Related]
12. Information needs of men regarding prostate cancer screening and the effect of a brief decision aid.
Sheridan SL; Felix K; Pignone MP; Lewis CL
Patient Educ Couns; 2004 Sep; 54(3):345-51. PubMed ID: 15324986
[TBL] [Abstract][Full Text] [Related]
13. [Cancer of the prostate: what treatment for what stage?].
Vanden Bossche M
Rev Med Brux; 1999 Sep; 20(4):A206-11. PubMed ID: 10523894
[TBL] [Abstract][Full Text] [Related]
14. Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer.
Puppo P; Introini C; Calvi P; Naselli A
Eur Urol; 2006 May; 49(5):873-8. PubMed ID: 16439052
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment predictors of time to cancer specific death after prostate specific antigen failure.
D'Amico AV; Cote K; Loffredo M; Renshaw AA; Chen MH
J Urol; 2003 Apr; 169(4):1320-4. PubMed ID: 12629352
[TBL] [Abstract][Full Text] [Related]
16. [The clinical usefulness of routine biopsy of the transition zone in the diagnosis of prostate cancer].
Morote Robles J; López Pacios M; Encabo Duró G; de Torres Ramírez I
Actas Urol Esp; 1999; 23(7):583-6. PubMed ID: 10488612
[TBL] [Abstract][Full Text] [Related]
17. Individualized decision-making for older men with prostate cancer: balancing cancer control with treatment consequences across the clinical spectrum.
Sajid S; Mohile SG; Szmulewitz R; Posadas E; Dale W
Semin Oncol; 2011 Apr; 38(2):309-25. PubMed ID: 21421119
[TBL] [Abstract][Full Text] [Related]
18. Results of conservative management of clinically localized prostate cancer.
Chodak GW; Thisted RA; Gerber GS; Johansson JE; Adolfsson J; Jones GW; Chisholm GD; Moskovitz B; Livne PM; Warner J
N Engl J Med; 1994 Jan; 330(4):242-8. PubMed ID: 8272085
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of conservative therapy in men presenting with voiding symptoms and prostate cancer.
Stattin P; Bergh A; Karlberg L; Tavelin B; Damber JE
Eur Urol; 1997; 32(4):404-9. PubMed ID: 9412796
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
Aus G
Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
